Organization | University of Sydney

University of Sydney Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Sydney Australia (1850)

Organization Overview

First Clinical Trial

1995

NCT00005776

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

ACRF Image X Institute, University of Sydney | Blacktown Hospital, NSW, Australia | Brain and Mind Research Institute, University of Sydney | Concord Hospital, NSW, Australia | Concord Repatriation, Australia | Department of Cardiology, Royal North Shore Hospital, Sydney, Australia | Dept. of Intensive Care, Nepean Hospital, U Sydney, Penrith, NSW, Australia | Human Nutrition Unit School of Molecular Bioscience, University of Sydney, Australia | Institute of Bone and Joint Research, University of Sydney | Nepean Blue Mountains Local Health District | Nepean Hospital, NSW, Australia | NHMRC Clinical Trials Centre, The University of Sydney | Princess Alexandra Hospital | Princess Alexandra Hospital, Brisbane, Australia | Royal Alexandra Hospital | Royal North Shore Hospital | Royal North Shore Hospital, NSW, Australia | Royal Prince Alfred | Royal Prince Alfred Hospital | Royal Prince Alfred Hospital, Camperdown (Australia) | Royal Prince Alfred Hospital NSW Australia | Royal Prince Alfred Hospital, NSW, Australia | Royal Prince Alfred Hospital, Sydney | Royal Prince Alfred Hospital, Sydney, Australia | Save Sight Institute, Deaprtment of Clinical Ophthalmology, University of Sydney | SAVE SIGHT INSTITUTE, UNIVERSITY OF SYDNEY, SYDNEY EYE HOSPITAL | School of Molecular Bioscience, University of Syndey, Australia | Sydney Cancer Centre at Royal Prince Alfred Hospital | Sydney Local Health District & The University of Sydney | Sydney Local Health District, The University of Sydney | The George Institute, University of Sydney | The University of Sydney - Brain and Mind Centre | University of Sydney | University of Sydney, Brain and Mind Centre | University of Sydney, Department of Peadiatrics | University of Sydney, Faculty of Health Sciences | University of Sydney, NHMRC Clinical Trials Centre | University of Sydney - Westmead | Westmead Cancer Care Centre | Westmead Hospital | Westmead Hospital, NSW, Australia | Westmead Hosptial | WSLHD, Department of Pharmacy, Westmead hospital, NSW, Australia

Active Ingredients

Drugs in Phase 4 Trials (23)

acamprosate (campral) (1 trial)

acetylcysteine (mucomyst) (3 trials)

aflibercept (zaltrap) (1 trial)

bacille calmette-guerin (2 trials)

bosentan (tracleer) (2 trials)

chlorhexidine (hibitane) (1 trial)

chondroitin (1 trial)

desogestrel (Mercilon) (1 trial)

esketamine (spravato) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

glucosamine (1 trial)

ibuprofen (motrin) (1 trial)

insulin human (humulin) (2 trials)

iodine (1 trial)

ketamine (ketalar) (2 trials)

montelukast (singulair) (1 trial)

morphine (1 trial)

naltrexone (revia) (3 trials)

neomycin (1 trial)

sitagliptin (januvia) (2 trials)

vancomycin (Vancocin) (1 trial)

yellow fever vaccine 17d strain (1 trial)

zoledronic acid (zometa) (2 trials)

Drugs in Phase 3 Trials (63)

acetylcarnitine (1 trial)

amlodipine (norvasc) (3 trials)

atorvastatin (lipitor) (1 trial)

baclofen (lioresal) (1 trial)

Bacterial Lysates (pulmonarom) (1 trial)

bleomycin (blenoxane) (2 trials)

bovine lactoferrin (1 trial)

carboplatin (paraplatin) (3 trials)

cisplatin (platinol) (2 trials)

cyclophosphamide (cytoxan) (3 trials)

dacarbazine (dtic-dome) (2 trials)

dapagliflozin (farxiga) (1 trial)

darolutamide (Nubeqa) (1 trial)

dexmedetomidine (precedex) (1 trial)

docetaxel (taxotere) (4 trials)

doxorubicin (Doxil) (2 trials)

durvalumab (imfinzi) (2 trials)

enzalutamide (xtandi) (2 trials)

epoetin (Epogen) (1 trial)

etoposide (vepesid) (2 trials)

fenofibrate (fenoglide) (1 trial)

Filgrastim (neupogen) (2 trials)

fluorouracil (efudex) (1 trial)

fosfomycin (monurol) (1 trial)

furosemide (lasix) (1 trial)

gliclazide (1 trial)

hydroxyethyl starch (voluven) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

indapamide (lozol) (4 trials)

irinotecan (Camptosar) (1 trial)

lemon eucalyptus (1 trial)

leucovorin (1 trial)

magnesium citrate (1 trial)

metformin (glucophage) (1 trial)

methoxyflurane (penthrane) (1 trial)

mirabegron (myrbetriq) (2 trials)

mitomycin (mutamycin) (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

nitric oxide (inomax) (1 trial)

nivolumab (opdivo) (3 trials)

obinutuzumab (gazyva) (1 trial)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (2 trials)

perindopril (aceon) (1 trial)

phylloquinone (1 trial)

prednisolone (hydeltra) (1 trial)

prednisone (meticorten) (2 trials)

procarbazine (matulane) (1 trial)

regorafenib (stivarga) (1 trial)

sacubitril (Entresto) (1 trial)

sargramostim (leukine) (2 trials)

sodium chloride (6 trials)

sodium thiosulfate (1 trial)

telmisartan (micardis) (2 trials)

tenecteplase (tnkase) (1 trial)

tipiracil (lonsurf) (1 trial)

topiramate (topamax) (1 trial)

triamcinolone (kenalog) (3 trials)

trifluridine (viroptic) (1 trial)

unfractionated heparin (1 trial)

valsartan (diovan) (1 trial)

vinblastine (velban) (1 trial)

vincristine (oncovin) (1 trial)

Drugs in Phase 2 Trials (56)

3,4-Methylenedioxymethamphetamine (1 trial)

abacavir (ziagen) (1 trial)

adeno-associated viral with human factor ix (1 trial)

arginine (1 trial)

avelumab (bavencio) (1 trial)

beta-glucans (1 trial)

bevacizumab (avastin) (2 trials)

bisoprolol (zebeta) (1 trial)

bnc 105p (1 trial)

candesartan (atacand) (2 trials)

cannabidiol (Epidiolex) (5 trials)

capecitabine (xeloda) (1 trial)

cend-1 (1 trial)

cetuximab (erbitux) (1 trial)

cu-64 sartate (1 trial)

cu-67 sartate (1 trial)

cyanocobalamin (berocca) (1 trial)

cyt997 (1 trial)

cytomegalovirus-specific t-cells (1 trial)

dabrafenib (tafinlar) (2 trials)

darbepoetin alfa (aranesp) (1 trial)

dexamethasone (1 trial)

dolutegravir (tivicay) (1 trial)

doxycycline (vibramycin) (1 trial)

elemental gold (2 trials)

erlotinib (tarceva) (1 trial)

fludrocortisone (florinef) (1 trial)

folic acid (1 trial)

gemcitabine (gemzar) (3 trials)

ingenol mebutate (picato) (1 trial)

ipilimumab (yervoy) (1 trial)

lactic acid (1 trial)

lamivudine (epivir) (1 trial)

live attenuated varicella vaccine (Varivax) (1 trial)

lovastatin (mevacor) (1 trial)

lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)

mannitol (Osmitrol) (1 trial)

n-(4-hydroxyphenyl)all-trans retinamide (1 trial)

necator americanus (1 trial)

niacin (1 trial)

octreotate (1 trial)

olorofim (1 trial)

pamrevlumab (1 trial)

panobinostat (farydak) (1 trial)

pembrolizumab (keytruda) (1 trial)

pi-88 (4 trials)

polidocanol (asclera) (1 trial)

repagermanium (1 trial)

rituximab (rituxan) (1 trial)

temozolomide (temodar) (2 trials)

tiopronin (thiola) (1 trial)

tirzepatide (Mounjaro) (1 trial)

trametinib (mekinist) (2 trials)

tremelimumab (Imjudo) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 1 Trials (14)

aav8-hfix19 (1 trial)

covigen (1 trial)

donor-derived wt1-ctl and p-ctl (1 trial)

donor stem cell (1 trial)

fluvax (1 trial)

icosapent ethyl (vascepa) (1 trial)

itraconazole (sporanox) (1 trial)

nexvax2 (1 trial)

phenoxodiol (1 trial)

tamoxifen (nolvadex) (1 trial)

targomirs (1 trial)

t lymphocytes (1 trial)

virus-specific T cells (1 trial)

zinc dichloride (1 trial)

Drugs in Other Trials (7)

carbimazole (1 trial)

enoxaparin (lovenox) (1 trial)

galactomannans (2 trials)

glucose (1 trial)

oryza sativa (1 trial)

oxygen (1 trial)

red blood cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Kidney Injury (Phase 3)

Acute Pain (Phase 4)

Alcoholism (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Arthritis, Rheumatoid (Phase 4)

Birth Weight (Phase 3)

Brain Diseases (Phase 3)

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Brain Ischemia (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Merkel Cell (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Cardiac Complexes, Premature (Phase 4)

Celiac Disease (Phase 2)

Cerebral Hemorrhage (Phase 3)

Cerebral Small Vessel Diseases (Phase 3)

Cognitive Dysfunction (Phase 3)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 2)

Critical Illness (Phase 2)

Cystic Fibrosis (Phase 3)

Delayed Graft Function (Phase 3)

Delirium (Phase 3)

Dementia, Vascular (Phase 3)

Demyelinating Diseases (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 3)

Diabetic Retinopathy (Phase 4)

Disease (Phase 4)

Disease Progression (Phase 4)

Edema (Phase 3)

Enterocolitis (Phase 3)

Enterocolitis, Necrotizing (Phase 3)

Fetal Nutrition Disorders (Phase 4)

Fibrosis (Phase 3)

Glioblastoma (Phase 2)

Heart Failure (Phase 3)

Hemophilia A (Phase 2)

Hemophilia B (Phase 2)

Hemorrhage (Phase 4)

Herpes Zoster (Phase 2)

HIV Infections (Phase 2)

Hodgkin Disease (Phase 3)

Hypercholesterolemia (Phase 2)

Hypersensitivity (Phase 2)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Hypoxia (Phase 3)

Hypoxia-Ischemia, Brain (Phase 3)

Idiopathic Pulmonary Fibrosis (Phase 2)

Impetigo (Phase 3)

Infarction (Phase 2)

Infections (Phase 4)

Insulin Resistance (Phase 2)

Invasive Fungal Infections (Phase 2)

Ischemia (Phase 3)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Liver Diseases (Phase 3)

Liver Diseases, Alcoholic (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 3)

Macular Edema (Phase 3)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Marijuana Abuse (Phase 2)

Melanoma (Phase 2)

Meningioma (Phase 2)

Menstruation Disturbances (Phase 4)

Mesothelioma (Phase 3)

Metabolic Syndrome (Phase 2)

Motor Neuron Disease (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Mycoses (Phase 2)

Myocardial Infarction (Phase 2)

Neonatal Sepsis (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Germ Cell and Embryonal (Phase 3)

Neuritis (Phase 2)

Neurodevelopmental Disorders (Phase 4)

Neuroendocrine Tumors (Phase 2)

Neurofibroma (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Nutrition Disorders (Phase 4)

Optic Nerve Diseases (Phase 2)

Optic Neuritis (Phase 2)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Osteoarthritis, Knee (Phase 4)

Osteonecrosis (Phase 2)

Osteoporosis (Phase 4)

Otitis Media (Phase 3)

Otitis Media with Effusion (Phase 3)

Ovarian Neoplasms (Phase 2)

Persistent Fetal Circulation Syndrome (Phase 3)

Pneumococcal Infections (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Aspiration (Phase 3)

Prostatic Neoplasms (Phase 3)

Pulmonary Fibrosis (Phase 2)

Pulmonary Valve Insufficiency (Phase 3)

Renal Insufficiency (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Insufficiency (Phase 3)

Retinal Diseases (Phase 4)

Rhabdomyolysis (Phase 2)

Sclerosis (Phase 2)

Shock (Phase 2)

Shock, Septic (Phase 2)

Skin Neoplasms (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Syndrome (Phase 3)

Tympanic Membrane Perforation (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Vascular Diseases (Phase 3)

Virus Diseases (Phase 3)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 137
# of Trial APIs: 163